Yea Christopher bought KALV
November 17, 2025 · Form 4 insider transaction
Yea Christopher bought 4,205 shares of KalVista Pharmaceuticals Inc, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
4,205
Price
N/A
Total value
N/A
InsiderYea Christopher
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateNovember 17, 2025
Filing dateNovember 19, 2025
Shares owned after136,257
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.